Trial site
The University of Tokyo Hospital
- 15running trials
- 2closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Fatty liver disease (MASLD/MASH)3 trials
- High blood pressure3 trials
- Pulmonary arterial hypertension3 trials
- Dermatomyositis and polymyositis (myositis)1 trial
- Frontotemporal dementia1 trial
- Liver cirrhosis1 trial
- Lupus (SLE)1 trial
- Mild cognitive impairment1 trial
- Ovarian cancer1 trial
- Phase
- Phase 312 trials
- Phase 15 trials
- Status
- Not yet recruiting5 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
- Actelion3 trials
- Boehringer Ingelheim2 trials
- ARCAGY/ GINECO GROUP1 trial
- argenx1 trial
- and 1 more
Running trials
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
Recruiting
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Recruiting
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease6 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Frontotemporal dementia1 recruiting
- Liver cirrhosis1 recruiting
- Mild cognitive impairment1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026